Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3427 Target Snapshot

D(2) dopamine receptor · SINGLE PROTEIN · Mus musculus

238Compounds
24Assays
4Approved Drugs
173.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P61168. Use UniProt P61168 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P61168 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats D(2) dopamine receptor as ChEMBL target CHEMBL3427, mapped to UniProt P61168. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
D(2) dopamine receptor
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3427
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P61168
D(2) dopamine receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether D(2) dopamine receptor is the right protein anchor across sources, using UniProt P61168 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelD(2) dopamine receptor
UniProt AccessionP61168
Component TypeProtein
Sequence Length444 aa

D(2) dopamine receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as D(2) dopamine receptor, mapped to UniProt P61168. Sequence length is 444 aa.

Mapped IDP61168
Review nameD(2) dopamine receptor
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC50159.0
KI14.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL343838 8.66 IC50 2.2 Preclinical
CHEMBL342742 8.33 IC50 4.7 Preclinical
CHEMBL170622 8.29 Ki 5.17 Preclinical
CHEMBL142850 8.24 IC50 5.8 Preclinical
CHEMBL143075 8.22 IC50 6.0 Preclinical
CHEMBL136064 8.15 IC50 7.0 Preclinical
CHEMBL141319 8.12 IC50 7.6 Preclinical
CHEMBL141392 8.11 IC50 7.8 Preclinical
CHEMBL141438 8.02 IC50 9.6 Preclinical
CHEMBL136794 8.0 IC50 10.0 Preclinical
Distribution

pChEMBL Value Distribution

25
5.0
32
5.5
20
6.0
10
6.5
6
7.0
12
7.5
9
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

RISPERIDONE
CHEMBL85
Approved 1993
CLOZAPINE
CHEMBL42
Approved 1989
CYPROHEPTADINE
CHEMBL516
Approved 1961
IMIPRAMINE
CHEMBL11
Approved 1959
Assay Landscape

Assay Landscape

24
Total Assays
116
Tested Compounds
2
Assay Types
Binding — 16 assays, 116 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 7 107 6.3
cell membrane format 5 1 8.3
assay format 1 3 5.7
cell-based format 1 2 6.5
organism-based format 1 0
tissue-based format 1 3 6.0
Functional — 8 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 6 0
cell membrane format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine